Given that CD44 has been proven to be a candidate marker for PCa stem cells [9], the initial aim of the present investigation was to detect whether the apoptosis resistance to poly(I:C) treatment can be linked to CD44 expression and to heterogeneous PCa phenotypes. Here, CD44 is linked to posterior cortical atrophy.